GLSI - NASDAQ

Greenwich LifeSciences, Inc.

GLSI·NASDAQ

$24.29

-15%

HealthcareBiotechnology

Greenwich LifeSciences, Inc., a clinical stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for breast cancer and other HER2/neu-expressing cancers. Its lead product candidate is the GP2, an immunotherapy, which has completed Phase IIb clinical trial to prevent breast cancer recurrences in patients who have previously undergone surgery. The company was formerly known as Norwell, Inc. and changed its name to Greenwich LifeSciences, Inc. in March 2018. Greenwich LifeSciences, Inc. was incorporated in 2006 and is headquartered in Stafford, Texas.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$356.53M

EPS-1.4300

P/E Ratio-16.99

Earnings Date06/02/2026

glsi

Shares Outstanding

Last Annual Value

13.53M

3-Year CAGR

5-Year CAGR

10-Year CAGR

Adjust for Inflation

Greenwich LifeSciences, Inc. Competitors Analysis of shares-outstanding

GLSI · NASDAQ

Company	shares-outstanding	CAGR 3Y	CAGR 5Y	CAGR 10Y
Greenwich LifeSciences, Inc. NASDAQ:GLSI	13.53M	1.8%	0.9%	N/A
TuHURA Biosciences, Inc. NASDAQ:HURA	47.93M	299.3%	343.8%	205.0%
Seer, Inc. NASDAQ:SEER	57.45M	-3.5%	-1.1%	N/A
Surrozen, Inc. NASDAQ:SRZN	7.48M	54.7%	26.2%	N/A
Acumen Pharmaceuticals, Inc. NASDAQ:ABOS	60.56M	7.6%	9.6%	N/A
Anixa Biosciences, Inc. NASDAQ:ANIX	32.45M	1.6%	2.6%	14.0%
C4 Therapeutics, Inc. NASDAQ:CCCC	82.89M	18.6%	12.5%	N/A
Cardiff Oncology, Inc. NASDAQ:CRDF	66.84M	14.4%	11.4%	66.0%
Nuvectis Pharma, Inc. NASDAQ:NVCT	21.81M	11.9%	11.4%	N/A
PepGen Inc. NASDAQ:PEPG	42.22M	21.1%	13.5%	N/A
Opus Genetics, Inc. NASDAQ:IRD	622.22M	206.6%	111.1%	N/A

Greenwich LifeSciences, Inc. Fair Value Envelope

GLSI · NASDAQ

Our analysis suggests that GLSI has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $24.29, this represents a potential HIDDEN relative to our calculated worth for Greenwich LifeSciences, Inc..

HIDDEN

Intrinsic Value

Current Price: $24.29

Related Guides

Blog Categories

Continue your GLSI research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.